Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5856113 | Regulatory Toxicology and Pharmacology | 2016 | 4 Pages |
Abstract
- The “Human Toxome Project” was funded (2011-2016) - for almost $7 million.
- Endocrine disruptors in human breast cancer MCF-7Â cells was chosen as the test case.
- They propose to discover clinically relevant endpoints without using lab animals.
- Examples are provided showing scientifically how impossible this proposal is.
- Questions should be asked, as to how this project was approved and funded.
Keywords
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Daniel W. Nebert, Magnus Ingelman-Sundberg,